578 filings
EFFECT
TENX
Tenax Therapeutics Inc
15 Apr 24
Notice of effectiveness
12:15am
EFFECT
TENX
Tenax Therapeutics Inc
15 Apr 24
Notice of effectiveness
12:15am
POS AM
TENX
Tenax Therapeutics Inc
11 Apr 24
Prospectus update (post-effective amendment)
4:59pm
POS AM
TENX
Tenax Therapeutics Inc
11 Apr 24
Prospectus update (post-effective amendment)
4:56pm
10-K
2023 FY
TENX
Tenax Therapeutics Inc
Annual report
28 Mar 24
2:02pm
8-K
57w93k3todsuhi f2
28 Mar 24
Tenax Therapeutics Provides Business and Clinical Development Updates with Full Year 2023 Financial Results
8:45am
424B3
q0ans
26 Feb 24
Prospectus supplement
4:31pm
424B3
8fpp9vs
26 Feb 24
Prospectus supplement
4:31pm
8-K
3voway7n
23 Feb 24
Other Events
4:30pm
424B3
sz357qf
21 Feb 24
Prospectus supplement
4:32pm
424B3
frar 6hnefy1
21 Feb 24
Prospectus supplement
4:30pm
8-K
m2947je3xfl52xj 65
20 Feb 24
Tenax Therapeutics Announces Global License Amendment that Significantly Expands Rights to Levosimendan
8:33am
424B3
afid024ylg9wc7b
13 Feb 24
Prospectus supplement
4:32pm
8-K
41ssk
12 Feb 24
Tenax Therapeutics Announces Pricing of Approximately $9 Million Public Offering
4:46pm
424B4
kboyvro7q80zkk
9 Feb 24
Prospectus supplement with pricing info
5:00pm
424B3
x2oh1
8 Feb 24
Prospectus supplement
4:51pm
EFFECT
1qxvzb7ijyrp
8 Feb 24
Notice of effectiveness
12:15am
8-K
exe 7nekvmx5552a0u
8 Feb 24
Over 40 sites (U.S. and Canada) have agreed to participate in the LEVEL study
12:00am
424B3
g8wwj g9e7p
6 Feb 24
Prospectus supplement
9:20am
8-K
kj5ii25fixfpl8y31otb
6 Feb 24
Other Events
8:56am